* Catalent Inc CTLT.N reported a quarterly adjusted loss
of 24
cents per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of 67
cents. The mean expectation of fourteen analysts for the
quarter was for a loss of 2 cents per share. Wall Street
expected results to range from -8 cents to 1 cents per share.
* Revenue fell 10.2% to $1.03 billion from a year ago;
analysts
expected $1.01 billion.
* Catalent Inc's reported EPS for the quarter was a loss of
$1.12.
* The company reported a quarterly loss of $204 million.
* Catalent Inc shares had risen by 25.9% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 148.6% in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 12
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "hold"
Wall Street's median 12-month price target for Catalent Inc is
$63.50
This summary was machine generated from LSEG data February 9 at
02:31 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.02 -0.24 Missed
Sep. 30 2023 -0.14 -0.10 Beat
Jun. 30 2023 0.10 0.09 Missed
Mar. 31 2023 -0.03 -0.09 Missed